NORD Issues Statement in Response to Proposed Repeal of the Orphan Drug Tax Credit (ODTC)
Written by Christina Jensen on November 2, 2017
Washington, D.C., November 2, 2017—The National Organization for Rare Disorders (NORD), the leading independent nonprofit organization representing the 30 million Americans with rare diseases, issued the following statement in response to the release of the Tax Cuts and Jobs Act, and the proposed repeal of the Orphan Drug Tax Credit… Read More